As for the roles of ATP7A and ATP7B, many studies have demonstrated that elevated expression of ATP7A and ATP7B is associated with poor outcomes of Pt-based cancer chemotherapy in cancers of ovary, breast, and lung (see review in [72] and references therein). Here, ATP7B is linked to cancer.